Option Care Health, Inc. (OPCH) fair value analysis

Nasdaq · Updated 2026-09-07

Option Care Health, Inc. is a healthcare company that provides infusion and ancillary services to patients in home and alternate care settings. The company operates across the United States, delivering medications and therapies to patients outside of traditional hospital environments.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, OPCH is trading at more than a 25% discount to estimated fair value.

OPCH currently ranks #8 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $23.70
Sector: Healthcare
12-month range: $20.03–$34.61

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: C
Leverage: Low
Margin trend: Contracting
Revenue growth: Strong
RSI zone: Neutral
50/200-day trend: Mixed
52-week position: The lower-middle quarter of its range
DCF cross-check: Undervalued

What our data shows for OPCH

Our model validated 17 trailing price-to-earnings windows for OPCH, built from quarterly earnings records.
Shares are trading in the lower third of their 12-month price range of $20.03–$34.61.
The 14-day relative strength index sits at a neutral 56.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for OPCH
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent OPCH news

TickrTrends' derived news-sentiment signal for OPCH is currently leaning positive, computed from recent coverage.

Option Care Health forecasts 2026 adjusted EBITDA of $480M-$495M while holding revenue outlook at $5.675B-$5.775B (NASDAQ:OPCH) (seekingalpha.com, 2026-07-29)
TickrTrends take: Option Care Health's 2026 guidance of 480 to 495 million dollars in adjusted EBITDA against a revenue range of 5675 to 5775 million dollars implies operating margins that investors tracking valuation should monitor for sustainability. TickrTrends currently identifies the stock as undervalued within the Healthcare sector, suggesting the market may not be fully pricing in the earnings power represented by these forward projections. The consistency of revenue guidance alongside EBITDA growth will be a key metric for determining whether the current undervaluation assessment reflects genuine opportunity or market skepticism about execution.
Option Care Health, Inc. (OPCH) Q2 2026 Earnings Call Transcript (seekingalpha.com, 2026-07-29)
TickrTrends take: Option Care Health operates in the Healthcare sector and is currently assessed as undervalued by TickrTrends' valuation metrics. The company's Q2 2026 earnings call represents an opportunity for valuation-focused readers to examine whether management commentary on operational performance, patient volumes, and margin trends supports the undervaluation thesis. Key items to monitor include any updates on revenue growth, cost structure changes, and capital allocation decisions that could affect whether the current valuation discount remains justified.
Option Care Health Q2 Earnings Call Highlights (finance.yahoo.com, 2026-07-29)
TickrTrends take: Option Care Health's second quarter earnings call provides an opportunity to assess whether the company's operational performance supports TickrTrends' current undervalued designation in the Healthcare sector. Investors focused on valuation should monitor commentary regarding revenue trends, margin expansion, and capital allocation decisions to determine if current market pricing accurately reflects the company's earnings power. The earnings discussion will be relevant for evaluating whether any changes in business fundamentals have occurred since the undervalued assessment was made.

What people are saying

Follow the OPCH conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — TickrTrends' derived indicators for OPCH showed a shift in valuation assessment this week. The DCF cross-check band moved from a fairly valued classification to an undervalued classification, aligning with the current valuation verdict of undervalued. This change suggests the company's intrinsic value estimate now exceeds its market price by a wider margin than previously indicated.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is OPCH stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), OPCH is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is OPCH's TickrTrends verdict?

OPCH's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does OPCH compare to other Healthcare stocks?

OPCH ranks #8 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is OPCH overbought or oversold?

OPCH's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

OPCH vs ADMA · OPCH vs ALGN · OPCH vs ANIP · OPCH vs ASTH · OPCH vs AZN